Train2Target | An integrated mulTidisciplinary appRoach towards a new generAtIon of aNtibiotics: Targeting function and cross-talk of bacterial Envelope proTein machineries 01-01-2017 - 31-12-2020 Show more information Organisation BIOVERSYS AG
TRIC-TB | Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new place for Ethionamide in 1st-line TB treatments. 01-05-2019 - 29-02-2024 Show more information Organisation BIOVERSYS AG